137 related articles for article (PubMed ID: 32437868)
1. Prognostic Significance of Perioperative C-Reactive Protein in Resected Non-Small Cell Lung Cancer.
Okada S; Shimomura M; Tsunezuka H; Teramukai S; Ishihara S; Shimada J; Inoue M
Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):1046-1055. PubMed ID: 32437868
[TBL] [Abstract][Full Text] [Related]
2. Perioperative CRP: A novel inflammation-based classification in gastric cancer for recurrence and chemotherapy benefit.
Lu J; Xu BB; Xue Z; Xie JW; Zheng CH; Huang CM; Li P
Cancer Med; 2021 Jan; 10(1):34-44. PubMed ID: 33270989
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of postoperative C-reactive protein elevation versus complication occurrence: a multicenter validation study.
Kurokawa Y; Yamashita K; Kawabata R; Fujita J; Imamura H; Takeno A; Takahashi T; Yamasaki M; Eguchi H; Doki Y
Gastric Cancer; 2020 Sep; 23(5):937-943. PubMed ID: 32314097
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Prognostic Impact of Severe Postoperative Complications After Lung Cancer Surgery.
Okada S; Shimada J; Kato D; Tsunezuka H; Teramukai S; Inoue M
Ann Surg Oncol; 2019 Jan; 26(1):230-237. PubMed ID: 30456673
[TBL] [Abstract][Full Text] [Related]
5. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of postoperative systemic inflammatory response in patients with stage II/III gastric cancer.
Kuroda K; Toyokawa T; Miki Y; Yoshii M; Tamura T; Tanaka H; Lee S; Muguruma K; Yashiro M; Ohira M
Sci Rep; 2022 Feb; 12(1):3025. PubMed ID: 35194147
[TBL] [Abstract][Full Text] [Related]
7. Which is a more reliable indicator of survival after gastric cancer surgery: Postoperative complication occurrence or C-reactive protein elevation?
Saito T; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
J Surg Oncol; 2015 Dec; 112(8):894-9. PubMed ID: 26458724
[TBL] [Abstract][Full Text] [Related]
8. Postoperative C-reactive Protein Is a Predictive Biomarker for Survival After Non-small Cell Lung Cancer Resection.
Shinohara S; Otsuki R; Onitsuka T; Machida K; Matsuo M; Nakagawa M; Sugaya M
Anticancer Res; 2019 Apr; 39(4):2193-2198. PubMed ID: 30952767
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Prognostic Nutritional Index After Surgical Treatment in Lung Cancer.
Okada S; Shimada J; Kato D; Tsunezuka H; Teramukai S; Inoue M
Ann Thorac Surg; 2017 Jul; 104(1):296-302. PubMed ID: 28433217
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Postoperative C-reactive Protein for Non-small Cell Lung Cancer Following Lobectomy.
Shinohara S; Sugaya M; Onitsuka T; Machida K; Matsuo M; Tanaka F
Anticancer Res; 2018 May; 38(5):3193-3198. PubMed ID: 29715162
[TBL] [Abstract][Full Text] [Related]
11. Platelet-to-Lymphocyte Ratio and Use of NSAIDs During the Perioperative Period as Prognostic Indicators in Patients With NSCLC Undergoing Surgery.
Lee BM; Rodriguez A; Mena G; Gottumukkala V; Mehran RJ; Rice DC; Feng L; Yu J; Cata JP
Cancer Control; 2016 Jul; 23(3):284-94. PubMed ID: 27556669
[TBL] [Abstract][Full Text] [Related]
12. Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study.
Choi JE; Villarreal J; Lasala J; Gottumukkala V; Mehran RJ; Rice D; Yu J; Feng L; Cata JP
Cancer Med; 2015 Jun; 4(6):825-33. PubMed ID: 25756351
[TBL] [Abstract][Full Text] [Related]
13. Body mass index, C-reactive protein and survival in smokers undergoing lobectomy for lung cancer†.
Nagata M; Ito H; Matsuzaki T; Furumoto H; Isaka T; Nishii T; Yokose T; Nakayama H
Eur J Cardiothorac Surg; 2017 Jun; 51(6):1164-1170. PubMed ID: 28199511
[TBL] [Abstract][Full Text] [Related]
14. The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer.
Shoji F; Haratake N; Akamine T; Takamori S; Katsura M; Takada K; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Feb; 37(2):741-747. PubMed ID: 28179325
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.
Mitsuyoshi T; Matsuo Y; Itou H; Shintani T; Iizuka Y; Kim YH; Mizowaki T
J Radiat Res; 2018 Jan; 59(1):50-57. PubMed ID: 29182777
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
[TBL] [Abstract][Full Text] [Related]
17. The impact of postoperative inflammation on recurrence in patients with colorectal cancer.
Matsubara D; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Kudou M; Konishi H; Komatsu S; Shiozaki A; Otsuji E
Int J Clin Oncol; 2020 Apr; 25(4):602-613. PubMed ID: 31758273
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer].
Shen L; Li ZM; Lu S
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):442-6. PubMed ID: 21875485
[TBL] [Abstract][Full Text] [Related]
19. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Lee JW; Na JO; Kang DY; Lee SY; Lee SM
Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
